BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  A Platform for Hope in the Face of Rare and Uncommon Diseases

  Acrotech is looking to launch drugs with either improved efficacy and/or safety over currently available treatments in the oncology, dermatology, neuroscience and rare disease spaces.

  February 28, 2022

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Business

  Biocon Buys Viatris’ Biosimilars in $3.3B Deal Aimed at Market Leadership

  Biocon Biologics has acquired its partner Viatris’ biosimilars assets. The transaction is part of an effort to create a global, vertically-integrated biosimilars leader.

  February 28, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Job Trends

  Life Science Industry Set Record Pace in 2021

  As we closed the books on year two of the COVID-19 pandemic, the Life Sciences market set records as the strongest in history.

  February 28, 2022

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Amryt’s Rare Skin Disease (Epidermolysis Bullosa) Treatment Rejected by FDA

  The FDA declined approval for Amryt Pharma’s therapeutic oleogel-S10. The topical gel is intended to treat a group of rare skin diseases called epidermolysis bullosa.

  February 28, 2022

   · 

  3 min read

   · 

  Hayley Shasteen
• 

  Career Advice

  Talent Acquisition vs Recruitment: What’s the Difference?

  Understanding the difference between talent acquisition and recruitment is vital not only for your hiring process but for the entire organization.

  February 28, 2022

   · 

  5 min read

   · 

  Brandi Marcene
• 

  Business

  DNA Damage Response Consortium Aims to Rapidly Develop Brain Cancer Therapies

  The National Brain Tumor Society is investing over $1 million in the DNA damage response consortium’s start. Here’s how this consortium will help researchers.

  February 28, 2022

   · 

  5 min read

   · 

  Abbey Glasure
• Spinal Intervention Market: Increase in the incidence of complications associated with the spine to drive the market

  Spinal intervention involves the treatment of all maladies that afflict the spine. The aim of spinal intervention is pain management, wherein the focus is solely on the spine.

  February 28, 2022

   · 

  7 min read
• Reusable Surgical Staplers Market: Introduction of Stapling Devices with Absorbable Staplers is Expected to Boost the Market

  Surgical staplers are referred as medical devices used in surgical procedures to seal or close a wound or incised portion of the body.

  February 28, 2022

   · 

  5 min read
• Pharmacovigilance Outsourcing Market: Increasing number of drug failure cases to drive the market

  Pharmacovigilance has evolved considerably thanks to strict monitoring in place jointly by the pharma consortium and regulatory bodies in several parts of the world.

  February 28, 2022

   · 

  6 min read
• Pharmaceutical Filtration Market: The microfiltration segment is estimated to hold the major share of the global market

  The process that helps separate suspended particles from a medium by passing them through a membrane is known as filtration.

  February 28, 2022

   · 

  5 min read